AzTrials
AzTrials

Eating Disorders in AdolescenceNCT04552639

Evaluation of Compulsive Exercise Group Therapy for Eating Disorders

A study testing Newbridge Eating disorders Activity Treatment group and Newbridge House treatment as usual in people with Eating Disorders in Adolescence, run by Newbridge House at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aims to generate hypotheses about whether a group intervention is effective in reducing motivation to compulsive exercise and/or eating disorder psychopathology when compared with a control group. This will be explored through a Randomized Control Trial. Read more about this study

Who is it for?
Ages 11 to 18 years, women only
Conditions the study is for
Eating Disorders in Adolescence
What is being tested?
Newbridge Eating disorders Activity Treatment group and Newbridge House treatment as usual
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited Kingdom
Study dates
1 Oct 2020to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 18 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Inpatients at Newbridge House
  • Aged 11-18
  • Primary diagnosis of any form of eating disorder
  • Females

Who cannot join

  • Previously received NEAT group at Newbridge House
  • Aged under 10 years
  • Severe learning disability
  • Inpatients without compulsive exercise behaviours
  • Day patients
  • Co-morbid psychosis
  • Males

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site, 1 recruiting
  • Newbridge House

    Birmingham, B74 3NE

    Rachel Matthews, 01212273891 ext. 01212273891, rachel.matthews@newbridge-health.org.uk

    Hubert Professor Lacey, 01212273891 ext. 01212273891, jhubertlacey@hotmail.com

    Recruiting

Other trials in United Kingdom

About this study

Official title: A Randomized Control Trial Study Evaluating a Compulsive Exercise Group for Adolescent Inpatients With Eating Disorders

The study aims to generate hypotheses about whether a group intervention is effective in reducing motivation to compulsive exercise and/or eating disorder psychopathology when compared with a control group. This will be explored through a Randomized Control Trial.

Being tested
Newbridge Eating disorders Activity Treatment group, Newbridge House treatment as usual

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Newbridge Eating disorders Activity Treatment groupBehavioural

    A compulsive exercise cognitive-behavioural based group, for children and adolescents diagnosed with an eating disorder. It was devised for eating disorders including Anorexia Nervosa, Bulimia Nervosa and Other Specified Feeding or Eating Disorder. This treatment is semi-structured and problem-oriented, which focuses on tackling the factors and processes that maintain compulsive exercise behaviour.

  • Newbridge House treatment as usualBehavioural

    Multi-disciplinary eating disorder treatment (including; psychiatry, individual therapy, group therapy, dietetic support, occupation therapy and nursing excluding NEAT group).

Study groups in NCT04552639
Study groupRoleWhat they receive
Treatment as usualActive comparatorTreatment as usual is offered. This includes; individual therapy, group therapy, dietetic support, occupational therapy, nursing and psychiatry, excluding the NEAT group.
Receives: Behavioral: Newbridge House treatment as usual
Treatment as usual and NEAT groupExperimentalTreatment as usual is offered. This includes; individual therapy, group therapy, dietetic support, occupational therapy, nursing and psychiatry, alongside NEAT group.
Receives: Behavioral: Newbridge Eating disorders Activity Treatment group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Compulsive Exercise Test

    Measured: Week 1 and week 7

Secondary outcomes (1)
  1. Change in Eating Disorder Examination Questionnaire

    Measured: Week 1 and week 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2020
  2. Study start1 Oct 2020
  3. Primary completion1 Oct 2022 (estimated)
  4. Study completion31 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04552639
Sponsor's protocol ID
281456
Status last verified
Sep 2021
First submitted
21 Aug 2020
Last updated
2 Sep 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Newbridge Eating disorders Activity Treatment group and Newbridge House treatment as usual in people with Eating Disorders in Adolescence, run by Newbridge House at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Compulsive Exercise Test (time frame: Week 1 and week 7). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in